SCHEMBL4938394

SCHEMBL4938394

C=C(COC(=O)c1ccccc1)C(=O)c1ccc(N(CC)CC)cc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
KDM4E B2RXH2 7/20 0.43
ALDH1A1 P00352 6/20 0.43
GAA P10253 5/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 8/20 0.41
LMNA P02545 5/20 0.41
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
MAOB P27338 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
HPGD P15428 5/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CNR2 P34972 1/20 0.37
ALOX12 P18054 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635671 0.80 MEN1 (0.64) MEN1KMT2ASMN1; SMN2L3MBTL1KDM4E
SCHEMBL2016398 0.79 MEN1 (0.60) MEN1KMT2ASMN1; SMN2L3MBTL1KDM4E
SCHEMBL28039761 0.79 SMN1; SMN2 (0.54) MEN1KMT2ASMN1; SMN2L3MBTL1KDM4E
SCHEMBL2780893 0.76 MEN1 (0.74) MEN1KMT2ASMN1; SMN2L3MBTL1KDM4E
SCHEMBL29437222 0.76 MEN1 (0.74) MEN1KMT2ASMN1; SMN2L3MBTL1KDM4E
SCHEMBL4558308 0.76 MEN1 (0.62) MEN1KMT2ASMN1; SMN2L3MBTL1KDM4E
SCHEMBL3518916 0.73 MEN1 (0.47) MEN1KMT2ASMN1; SMN2L3MBTL1KDM4E
SCHEMBL27913467 0.73 MEN1 (0.89) MEN1KMT2ASMN1; SMN2L3MBTL1KDM4E
Benzoic Acid SCHEMBL28747841 0.73 MEN1 (0.72) MEN1KMT2ASMN1; SMN2L3MBTL1KDM4E
SCHEMBL12936397 0.73 SMN1; SMN2 (0.65) MEN1KMT2ASMN1; SMN2L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080305056-A1 STABLE, LOW VISCOSITY COSMETIC COMPOSITIONS EVONIK GOLDSCHMIDT GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080305056-A1 STABLE, LOW VISCOSITY COSMETIC COMPOSITIONS QARS1, QPCTL, CUTA MEN1 2678/4885KMT2A 383/4885SMN1; SMN2 4020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.